The FDA can better leverage Advisory Committee membership through expanding the role of the chair, overall committee composition, implementing mandatory training programs, and streamlining the conflict of interest process.

The federal government plays a critical role in correcting bias in technologies and incentivizing future processes for equitable innovation.

The urgency of building new clean energy infrastructure creates a critical window of opportunity for permitting reform. 

We are working with development experts to identify a set of cost-effective interventions and pathways to scale within USAID and other federal programs.

Both established and new approaches to federal evidence use — including living evidence synthesis, public engagement, and expert advising — face obstacles to reaching their potential.